News
MMIRF
0.045
NaN%
--
Weekly Report: what happened at MMIRF last week (0420-0424)?
Weekly Report · 4d ago
Weekly Report: what happened at MMIRF last week (0413-0417)?
Weekly Report · 04/20 10:24
Weekly Report: what happened at MMIRF last week (0406-0410)?
Weekly Report · 04/13 10:28
Weekly Report: what happened at MMIRF last week (0330-0403)?
Weekly Report · 04/06 10:28
MedMira Inc. reports Q2 results
Seeking Alpha · 04/02 13:52
Weekly Report: what happened at MMIRF last week (0323-0327)?
Weekly Report · 03/30 10:29
Weekly Report: what happened at MMIRF last week (0316-0320)?
Weekly Report · 03/23 10:25
Weekly Report: what happened at MMIRF last week (0309-0313)?
Weekly Report · 03/16 10:24
Weekly Report: what happened at MMIRF last week (0302-0306)?
Weekly Report · 03/09 10:24
Weekly Report: what happened at MMIRF last week (0223-0227)?
Weekly Report · 03/02 10:23
Weekly Report: what happened at MMIRF last week (0216-0220)?
Weekly Report · 02/23 10:23
Weekly Report: what happened at MMIRF last week (0209-0213)?
Weekly Report · 02/16 10:23
Weekly Report: what happened at MMIRF last week (0202-0206)?
Weekly Report · 02/09 10:25
Weekly Report: what happened at MMIRF last week (0126-0130)?
Weekly Report · 02/02 10:25
Weekly Report: what happened at MMIRF last week (0119-0123)?
Weekly Report · 01/26 10:24
Weekly Report: what happened at MMIRF last week (0112-0116)?
Weekly Report · 01/19 10:31
Weekly Report: what happened at MMIRF last week (0105-0109)?
Weekly Report · 01/12 10:30
Weekly Report: what happened at MMIRF last week (1229-0102)?
Weekly Report · 01/05 10:24
Medmira reports Q1 results
Seeking Alpha · 12/31/2025 11:39
Weekly Report: what happened at MMIRF last week (1222-1226)?
Weekly Report · 12/29/2025 10:23
More
Webull provides a variety of real-time MMIRF stock news. You can receive the latest news about Medmira Inc through multiple platforms. This information may help you make smarter investment decisions.
About MMIRF
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with an instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.